nodes	percent_of_prediction	percent_of_DWPC	metapath
Pancuronium—BCHE—Ramipril—type 2 diabetes mellitus	0.329	0.59	CbGbCtD
Pancuronium—SLC22A2—Metformin—type 2 diabetes mellitus	0.122	0.22	CbGbCtD
Pancuronium—SLC22A1—Metformin—type 2 diabetes mellitus	0.106	0.191	CbGbCtD
Pancuronium—Drug interaction—Chlorpropamide—type 2 diabetes mellitus	0.0107	0.048	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Repaglinide—type 2 diabetes mellitus	0.00597	0.0268	CcSEcCtD
Pancuronium—Erythema—Tolbutamide—type 2 diabetes mellitus	0.00477	0.0214	CcSEcCtD
Pancuronium—Drug interaction—Valsartan—type 2 diabetes mellitus	0.00451	0.0202	CcSEcCtD
Pancuronium—Drug interaction—Orlistat—type 2 diabetes mellitus	0.00445	0.02	CcSEcCtD
Pancuronium—Salivary hypersecretion—Gliclazide—type 2 diabetes mellitus	0.00442	0.0198	CcSEcCtD
Pancuronium—Erythema—Tolazamide—type 2 diabetes mellitus	0.00434	0.0195	CcSEcCtD
Pancuronium—Erythema—Acarbose—type 2 diabetes mellitus	0.00417	0.0187	CcSEcCtD
Pancuronium—Drug interaction—Irbesartan—type 2 diabetes mellitus	0.00387	0.0174	CcSEcCtD
Pancuronium—Anaphylactic shock—Linagliptin—type 2 diabetes mellitus	0.0035	0.0157	CcSEcCtD
Pancuronium—Erythema—Repaglinide—type 2 diabetes mellitus	0.00348	0.0156	CcSEcCtD
Pancuronium—Drug interaction—Ramipril—type 2 diabetes mellitus	0.00312	0.014	CcSEcCtD
Pancuronium—Flushing—Glipizide—type 2 diabetes mellitus	0.00307	0.0138	CcSEcCtD
Pancuronium—Erythema—Glipizide—type 2 diabetes mellitus	0.00288	0.0129	CcSEcCtD
Pancuronium—Anaphylactic shock—Repaglinide—type 2 diabetes mellitus	0.00284	0.0127	CcSEcCtD
Pancuronium—Salivary hypersecretion—Ramipril—type 2 diabetes mellitus	0.00281	0.0126	CcSEcCtD
Pancuronium—Rash—Miglitol—type 2 diabetes mellitus	0.00273	0.0123	CcSEcCtD
Pancuronium—Dermatitis—Miglitol—type 2 diabetes mellitus	0.00273	0.0122	CcSEcCtD
Pancuronium—Erythema—Glimepiride—type 2 diabetes mellitus	0.00269	0.0121	CcSEcCtD
Pancuronium—Anaphylactic shock—Rosiglitazone—type 2 diabetes mellitus	0.00268	0.012	CcSEcCtD
Pancuronium—Muscular weakness—Valsartan—type 2 diabetes mellitus	0.00268	0.012	CcSEcCtD
Pancuronium—Hypersensitivity—Linagliptin—type 2 diabetes mellitus	0.00258	0.0116	CcSEcCtD
Pancuronium—Bronchospasm—Orlistat—type 2 diabetes mellitus	0.00255	0.0114	CcSEcCtD
Pancuronium—Hypersensitivity—Acarbose—type 2 diabetes mellitus	0.00251	0.0113	CcSEcCtD
Pancuronium—Rash—Tolbutamide—type 2 diabetes mellitus	0.00245	0.011	CcSEcCtD
Pancuronium—Hypersensitivity—Nateglinide—type 2 diabetes mellitus	0.00242	0.0109	CcSEcCtD
Pancuronium—Muscular weakness—Irbesartan—type 2 diabetes mellitus	0.0023	0.0103	CcSEcCtD
Pancuronium—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.00225	0.0101	CcSEcCtD
Pancuronium—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00223	0.01	CcSEcCtD
Pancuronium—Rash—Tolazamide—type 2 diabetes mellitus	0.00223	0.01	CcSEcCtD
Pancuronium—Erythema—Glyburide—type 2 diabetes mellitus	0.00221	0.00994	CcSEcCtD
Pancuronium—Rash—Linagliptin—type 2 diabetes mellitus	0.00221	0.00992	CcSEcCtD
Pancuronium—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00221	0.00991	CcSEcCtD
Pancuronium—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00219	0.00984	CcSEcCtD
Pancuronium—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00218	0.00981	CcSEcCtD
Pancuronium—Anaphylactoid reaction—Ramipril—type 2 diabetes mellitus	0.00217	0.00976	CcSEcCtD
Pancuronium—Muscular weakness—Losartan—type 2 diabetes mellitus	0.00216	0.00972	CcSEcCtD
Pancuronium—Rash—Acarbose—type 2 diabetes mellitus	0.00214	0.00963	CcSEcCtD
Pancuronium—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00214	0.00962	CcSEcCtD
Pancuronium—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.00214	0.00961	CcSEcCtD
Pancuronium—Flushing—Gliclazide—type 2 diabetes mellitus	0.00212	0.00952	CcSEcCtD
Pancuronium—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00209	0.00939	CcSEcCtD
Pancuronium—Rash—Nateglinide—type 2 diabetes mellitus	0.00207	0.00929	CcSEcCtD
Pancuronium—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00207	0.00928	CcSEcCtD
Pancuronium—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00205	0.0092	CcSEcCtD
Pancuronium—Erythema—Gliclazide—type 2 diabetes mellitus	0.00199	0.00893	CcSEcCtD
Pancuronium—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00193	0.00867	CcSEcCtD
Pancuronium—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00185	0.0083	CcSEcCtD
Pancuronium—Rash—Repaglinide—type 2 diabetes mellitus	0.00179	0.00804	CcSEcCtD
Pancuronium—Bronchospasm—Ramipril—type 2 diabetes mellitus	0.00179	0.00803	CcSEcCtD
Pancuronium—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00179	0.00803	CcSEcCtD
Pancuronium—Flushing—Metformin—type 2 diabetes mellitus	0.00177	0.00797	CcSEcCtD
Pancuronium—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00173	0.00777	CcSEcCtD
Pancuronium—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00169	0.0076	CcSEcCtD
Pancuronium—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00169	0.00759	CcSEcCtD
Pancuronium—Hypotension—Glyburide—type 2 diabetes mellitus	0.00169	0.00758	CcSEcCtD
Pancuronium—Flushing—Irbesartan—type 2 diabetes mellitus	0.00167	0.00752	CcSEcCtD
Pancuronium—Erythema—Metformin—type 2 diabetes mellitus	0.00166	0.00747	CcSEcCtD
Pancuronium—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00166	0.00744	CcSEcCtD
Pancuronium—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00161	0.00725	CcSEcCtD
Pancuronium—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00161	0.00723	CcSEcCtD
Pancuronium—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.00158	0.00711	CcSEcCtD
Pancuronium—Flushing—Losartan—type 2 diabetes mellitus	0.00158	0.00707	CcSEcCtD
Pancuronium—Erythema—Irbesartan—type 2 diabetes mellitus	0.00157	0.00705	CcSEcCtD
Pancuronium—Hypotension—Gliclazide—type 2 diabetes mellitus	0.00152	0.00681	CcSEcCtD
Pancuronium—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00149	0.0067	CcSEcCtD
Pancuronium—Rash—Glipizide—type 2 diabetes mellitus	0.00148	0.00665	CcSEcCtD
Pancuronium—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00148	0.00664	CcSEcCtD
Pancuronium—Erythema—Losartan—type 2 diabetes mellitus	0.00148	0.00664	CcSEcCtD
Pancuronium—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00147	0.00662	CcSEcCtD
Pancuronium—Hypotension—Valsartan—type 2 diabetes mellitus	0.00139	0.00626	CcSEcCtD
Pancuronium—Rash—Glimepiride—type 2 diabetes mellitus	0.00138	0.00621	CcSEcCtD
Pancuronium—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00138	0.0062	CcSEcCtD
Pancuronium—Rash—Sitagliptin—type 2 diabetes mellitus	0.00138	0.00619	CcSEcCtD
Pancuronium—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00138	0.00618	CcSEcCtD
Pancuronium—Flushing—Ramipril—type 2 diabetes mellitus	0.00135	0.00607	CcSEcCtD
Pancuronium—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00133	0.00598	CcSEcCtD
Pancuronium—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00128	0.00575	CcSEcCtD
Pancuronium—Hypotension—Metformin—type 2 diabetes mellitus	0.00127	0.0057	CcSEcCtD
Pancuronium—Erythema—Ramipril—type 2 diabetes mellitus	0.00127	0.00569	CcSEcCtD
Pancuronium—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00125	0.00562	CcSEcCtD
Pancuronium—Rash—Bromocriptine—type 2 diabetes mellitus	0.00125	0.0056	CcSEcCtD
Pancuronium—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00125	0.00559	CcSEcCtD
Pancuronium—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00121	0.00542	CcSEcCtD
Pancuronium—Hypotension—Irbesartan—type 2 diabetes mellitus	0.0012	0.00538	CcSEcCtD
Pancuronium—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.0012	0.00537	CcSEcCtD
Pancuronium—Tachycardia—Losartan—type 2 diabetes mellitus	0.00118	0.00529	CcSEcCtD
Pancuronium—Rash—Glyburide—type 2 diabetes mellitus	0.00114	0.00512	CcSEcCtD
Pancuronium—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00114	0.00511	CcSEcCtD
Pancuronium—Hypotension—Losartan—type 2 diabetes mellitus	0.00113	0.00506	CcSEcCtD
Pancuronium—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.0011	0.00493	CcSEcCtD
Pancuronium—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00109	0.00487	CcSEcCtD
Pancuronium—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.00103	0.00464	CcSEcCtD
Pancuronium—Rash—Gliclazide—type 2 diabetes mellitus	0.00102	0.0046	CcSEcCtD
Pancuronium—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00102	0.00459	CcSEcCtD
Pancuronium—Tachycardia—Ramipril—type 2 diabetes mellitus	0.00101	0.00453	CcSEcCtD
Pancuronium—Hypotension—Ramipril—type 2 diabetes mellitus	0.000966	0.00434	CcSEcCtD
Pancuronium—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000944	0.00424	CcSEcCtD
Pancuronium—Rash—Valsartan—type 2 diabetes mellitus	0.00094	0.00422	CcSEcCtD
Pancuronium—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000939	0.00422	CcSEcCtD
Pancuronium—Rash—Orlistat—type 2 diabetes mellitus	0.000929	0.00417	CcSEcCtD
Pancuronium—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000928	0.00417	CcSEcCtD
Pancuronium—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000889	0.00399	CcSEcCtD
Pancuronium—Rash—Metformin—type 2 diabetes mellitus	0.000856	0.00384	CcSEcCtD
Pancuronium—Dermatitis—Metformin—type 2 diabetes mellitus	0.000855	0.00384	CcSEcCtD
Pancuronium—Rash—Irbesartan—type 2 diabetes mellitus	0.000808	0.00363	CcSEcCtD
Pancuronium—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000807	0.00362	CcSEcCtD
Pancuronium—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000762	0.00342	CcSEcCtD
Pancuronium—Rash—Losartan—type 2 diabetes mellitus	0.00076	0.00341	CcSEcCtD
Pancuronium—Dermatitis—Losartan—type 2 diabetes mellitus	0.00076	0.00341	CcSEcCtD
Pancuronium—Rash—Ramipril—type 2 diabetes mellitus	0.000652	0.00293	CcSEcCtD
Pancuronium—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000651	0.00293	CcSEcCtD
Pancuronium—CHRM3—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	3.86e-05	0.000175	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—APOB—type 2 diabetes mellitus	3.84e-05	0.000174	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.84e-05	0.000174	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	3.82e-05	0.000174	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—INSR—type 2 diabetes mellitus	3.81e-05	0.000173	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.8e-05	0.000173	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CYP2E1—type 2 diabetes mellitus	3.79e-05	0.000172	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—INSR—type 2 diabetes mellitus	3.78e-05	0.000172	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—AGT—type 2 diabetes mellitus	3.76e-05	0.000171	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.75e-05	0.00017	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—SLC2A1—type 2 diabetes mellitus	3.74e-05	0.00017	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CYP1A2—type 2 diabetes mellitus	3.74e-05	0.00017	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	3.74e-05	0.00017	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—GSTM1—type 2 diabetes mellitus	3.73e-05	0.00017	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.72e-05	0.000169	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	3.72e-05	0.000169	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.71e-05	0.000169	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	3.7e-05	0.000168	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.69e-05	0.000168	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.67e-05	0.000167	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—LPL—type 2 diabetes mellitus	3.66e-05	0.000167	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CYP3A4—type 2 diabetes mellitus	3.65e-05	0.000166	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.64e-05	0.000165	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—GNB3—type 2 diabetes mellitus	3.59e-05	0.000163	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.59e-05	0.000163	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—C3—type 2 diabetes mellitus	3.59e-05	0.000163	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GCG—type 2 diabetes mellitus	3.59e-05	0.000163	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—SLC2A4—type 2 diabetes mellitus	3.59e-05	0.000163	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ADCY5—type 2 diabetes mellitus	3.59e-05	0.000163	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—HMOX1—type 2 diabetes mellitus	3.58e-05	0.000163	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—GPX1—type 2 diabetes mellitus	3.57e-05	0.000162	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.57e-05	0.000162	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—C3—type 2 diabetes mellitus	3.55e-05	0.000162	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.53e-05	0.000161	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—CAT—type 2 diabetes mellitus	3.53e-05	0.00016	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—CD36—type 2 diabetes mellitus	3.48e-05	0.000158	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	3.47e-05	0.000158	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HTR2C—type 2 diabetes mellitus	3.46e-05	0.000157	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PSMD6—type 2 diabetes mellitus	3.46e-05	0.000157	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	3.44e-05	0.000156	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PPP2CA—type 2 diabetes mellitus	3.44e-05	0.000156	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	3.43e-05	0.000156	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	3.43e-05	0.000156	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—APOB—type 2 diabetes mellitus	3.43e-05	0.000156	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—AGT—type 2 diabetes mellitus	3.41e-05	0.000155	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—AGT—type 2 diabetes mellitus	3.38e-05	0.000154	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	3.37e-05	0.000153	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—CALM1—type 2 diabetes mellitus	3.35e-05	0.000152	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CYBA—type 2 diabetes mellitus	3.35e-05	0.000152	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—GNB3—type 2 diabetes mellitus	3.35e-05	0.000152	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.35e-05	0.000152	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	3.33e-05	0.000152	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—HMOX1—type 2 diabetes mellitus	3.33e-05	0.000152	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—GSTM1—type 2 diabetes mellitus	3.33e-05	0.000152	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	3.32e-05	0.000151	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	3.32e-05	0.000151	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—MTHFR—type 2 diabetes mellitus	3.3e-05	0.00015	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	3.3e-05	0.00015	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CAT—type 2 diabetes mellitus	3.29e-05	0.00015	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PLAT—type 2 diabetes mellitus	3.28e-05	0.000149	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—GHRL—type 2 diabetes mellitus	3.28e-05	0.000149	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—LPL—type 2 diabetes mellitus	3.27e-05	0.000149	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	3.26e-05	0.000148	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	3.25e-05	0.000148	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	3.25e-05	0.000148	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CALCA—type 2 diabetes mellitus	3.24e-05	0.000147	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PPARA—type 2 diabetes mellitus	3.24e-05	0.000147	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	3.21e-05	0.000146	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ADCY5—type 2 diabetes mellitus	3.2e-05	0.000146	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—APOB—type 2 diabetes mellitus	3.19e-05	0.000145	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—GPX1—type 2 diabetes mellitus	3.19e-05	0.000145	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	3.15e-05	0.000143	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—AGT—type 2 diabetes mellitus	3.13e-05	0.000142	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	3.12e-05	0.000142	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—CD36—type 2 diabetes mellitus	3.11e-05	0.000141	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—GSTM1—type 2 diabetes mellitus	3.11e-05	0.000141	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GNB3—type 2 diabetes mellitus	3.09e-05	0.000141	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.09e-05	0.000141	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—CALM1—type 2 diabetes mellitus	3.08e-05	0.00014	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—HMOX1—type 2 diabetes mellitus	3.08e-05	0.00014	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—APOE—type 2 diabetes mellitus	3.07e-05	0.00014	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PPP2CA—type 2 diabetes mellitus	3.07e-05	0.00014	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.05e-05	0.000139	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—LPL—type 2 diabetes mellitus	3.05e-05	0.000139	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.04e-05	0.000138	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CAT—type 2 diabetes mellitus	3.04e-05	0.000138	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—APOA1—type 2 diabetes mellitus	3.04e-05	0.000138	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	3.02e-05	0.000137	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	3.01e-05	0.000137	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—GCG—type 2 diabetes mellitus	3e-05	0.000136	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	3e-05	0.000136	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ADCY5—type 2 diabetes mellitus	2.99e-05	0.000136	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—GPX1—type 2 diabetes mellitus	2.97e-05	0.000135	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	2.97e-05	0.000135	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.97e-05	0.000135	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.95e-05	0.000134	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—APOB—type 2 diabetes mellitus	2.95e-05	0.000134	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.95e-05	0.000134	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.94e-05	0.000134	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.92e-05	0.000133	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.91e-05	0.000133	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CD36—type 2 diabetes mellitus	2.9e-05	0.000132	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PPARA—type 2 diabetes mellitus	2.89e-05	0.000131	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GSTM1—type 2 diabetes mellitus	2.87e-05	0.00013	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.86e-05	0.00013	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—LPL—type 2 diabetes mellitus	2.82e-05	0.000128	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.81e-05	0.000128	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—AGT—type 2 diabetes mellitus	2.8e-05	0.000127	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.78e-05	0.000126	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.76e-05	0.000125	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ADCY5—type 2 diabetes mellitus	2.76e-05	0.000125	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.76e-05	0.000125	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—CALM1—type 2 diabetes mellitus	2.75e-05	0.000125	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—GPX1—type 2 diabetes mellitus	2.75e-05	0.000125	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—MTHFR—type 2 diabetes mellitus	2.75e-05	0.000125	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—APOE—type 2 diabetes mellitus	2.74e-05	0.000125	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.73e-05	0.000124	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.73e-05	0.000124	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—APOA1—type 2 diabetes mellitus	2.71e-05	0.000123	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PPARA—type 2 diabetes mellitus	2.69e-05	0.000122	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	2.68e-05	0.000122	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	2.67e-05	0.000122	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	2.64e-05	0.00012	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—INS—type 2 diabetes mellitus	2.62e-05	0.000119	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.61e-05	0.000119	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—AGT—type 2 diabetes mellitus	2.61e-05	0.000119	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.59e-05	0.000118	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.59e-05	0.000118	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—CALM1—type 2 diabetes mellitus	2.56e-05	0.000117	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.56e-05	0.000116	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—APOE—type 2 diabetes mellitus	2.56e-05	0.000116	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.55e-05	0.000116	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	2.55e-05	0.000116	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.54e-05	0.000116	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	2.54e-05	0.000115	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.53e-05	0.000115	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	2.53e-05	0.000115	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.53e-05	0.000115	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—APOA1—type 2 diabetes mellitus	2.53e-05	0.000115	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.52e-05	0.000114	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.51e-05	0.000114	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.5e-05	0.000114	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	2.49e-05	0.000113	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.48e-05	0.000113	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	2.47e-05	0.000112	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.46e-05	0.000112	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	2.44e-05	0.000111	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.43e-05	0.000111	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.43e-05	0.00011	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	2.41e-05	0.00011	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—ALB—type 2 diabetes mellitus	2.4e-05	0.000109	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.4e-05	0.000109	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PPARG—type 2 diabetes mellitus	2.39e-05	0.000109	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	2.37e-05	0.000108	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	2.36e-05	0.000107	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	2.36e-05	0.000107	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—INS—type 2 diabetes mellitus	2.34e-05	0.000107	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	2.33e-05	0.000106	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	2.33e-05	0.000106	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.31e-05	0.000105	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	2.3e-05	0.000105	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	2.3e-05	0.000105	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.28e-05	0.000104	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PPARG—type 2 diabetes mellitus	2.23e-05	0.000101	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.21e-05	0.0001	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	2.19e-05	9.95e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—INS—type 2 diabetes mellitus	2.18e-05	9.93e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.17e-05	9.87e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	2.15e-05	9.77e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—ALB—type 2 diabetes mellitus	2.15e-05	9.77e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	2.12e-05	9.64e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	2.1e-05	9.57e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	2.1e-05	9.55e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	2.06e-05	9.35e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.05e-05	9.34e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—NOS3—type 2 diabetes mellitus	2.05e-05	9.34e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2.02e-05	9.2e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	2.02e-05	9.17e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—INS—type 2 diabetes mellitus	2.02e-05	9.17e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	2.01e-05	9.16e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	2e-05	9.11e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—ALB—type 2 diabetes mellitus	2e-05	9.1e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	2e-05	9.08e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	2e-05	9.07e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.98e-05	9.01e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	1.97e-05	8.98e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	1.97e-05	8.98e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.96e-05	8.92e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.96e-05	8.89e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.96e-05	8.89e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.95e-05	8.87e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.93e-05	8.79e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.91e-05	8.71e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—NOS3—type 2 diabetes mellitus	1.91e-05	8.71e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.88e-05	8.54e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.86e-05	8.47e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	1.85e-05	8.41e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.84e-05	8.38e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	1.77e-05	8.04e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	1.77e-05	8.04e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.76e-05	8.01e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.75e-05	7.96e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.74e-05	7.93e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	1.69e-05	7.67e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	1.67e-05	7.59e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.66e-05	7.54e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.64e-05	7.47e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.63e-05	7.42e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.63e-05	7.41e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.62e-05	7.38e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	1.62e-05	7.36e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.62e-05	7.35e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.61e-05	7.34e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.61e-05	7.31e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.55e-05	7.04e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.53e-05	6.98e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.48e-05	6.72e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.48e-05	6.72e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.46e-05	6.66e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.46e-05	6.66e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	1.39e-05	6.33e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.38e-05	6.27e-05	CbGpPWpGaD
Pancuronium—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.27e-05	5.76e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.26e-05	5.71e-05	CbGpPWpGaD
Pancuronium—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.26e-05	5.71e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.25e-05	5.67e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.24e-05	5.65e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.24e-05	5.62e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.19e-05	5.4e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.18e-05	5.34e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.17e-05	5.34e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.16e-05	5.29e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.15e-05	5.23e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.14e-05	5.18e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.09e-05	4.97e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.08e-05	4.93e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.07e-05	4.84e-05	CbGpPWpGaD
Pancuronium—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	1.06e-05	4.81e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.06e-05	4.8e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.78e-06	4.45e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.68e-06	4.4e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.59e-06	4.36e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.5e-06	4.32e-05	CbGpPWpGaD
Pancuronium—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	9.44e-06	4.29e-05	CbGpPWpGaD
Pancuronium—SLC22A1—Metabolism—AKT1—type 2 diabetes mellitus	8.8e-06	4e-05	CbGpPWpGaD
Pancuronium—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	8.13e-06	3.7e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	7.37e-06	3.35e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	7.3e-06	3.32e-05	CbGpPWpGaD
Pancuronium—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.8e-06	3.09e-05	CbGpPWpGaD
Pancuronium—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.73e-06	3.06e-05	CbGpPWpGaD
